Apria is a leading provider of home medical equipment and clinical support, serving more than 2 million patients annually. The company offers a comprehensive range of products and services for in-home care, including respiratory therapy, obstructive sleep apnea treatment, and negative pressure wound therapy. With a focus on high-quality and high-touch service, Apria aims to bridge the gap between acute care settings and home healthcare, while also striving to be a low-cost operator. This approach not only provides a compelling value proposition to patients, providers, and payors but also allows for cost reduction in treatment. Currently, Apria serves nearly 2 million patients through approximately 275 branches across the USA. Although specific details about the founding date, industries, headquarter, and last investment are not provided, Apria presents a promising opportunity for investors in the thriving home healthcare sector.
There is no investment information
No recent news or press coverage available for Apria.